Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.370
Peer-review started: October 18, 2023
First decision: December 6, 2023
Revised: December 21, 2023
Accepted: January 15, 2024
Article in press: January 15, 2024
Published online: March 19, 2024
Processing time: 153 Days and 1.1 Hours
Dexmedetomidine and propofol are two sedatives used for long-term sedation. It remains unclear whether dexme
In this study, we designed a single-center, prospective, randomized controlled study to compare the brain-protective effects of dexmedetomidine versus propofol for sedation during prolonged mechanical ventilation in non-brain-injured patients.
To compare the neuroprotective effects of dexmedetomidine and propofol for sedation during prolonged mechanical ventilation in patients without brain injury.
Patients who underwent mechanical ventilation for > 72 h were randomly assigned to receive sedation with dexme
The sedative effects of dexmedetomidine and propofol during prolonged mechanical ventilation in patients without brain injury were similar. Serum S100-β and NSE levels in the propofol group were higher in contrast with those in the dexmedetomidine group during prolonged mechanical ventilation in patients without brain injury. Serum levels of S100-β (first 6 d) as well as NSE (first 5 d) levels in the propofol group were obviously higher in contrast with those in the dexmedetomidine group during the early stage of mechanical ventilation and sedation.
Dexmedetomidine exhibited stronger protective effects on the brain than propofol for long-term mechanical ventilation in patients without brain injury.
We believe that the findings regarding the brain protective effect in the later stage of mechanical ventilation and sedation may be biased.